Knee Replacement Implants

Knee arthroplasty is indicated for end-stage degenerative joint disease, as evidenced by radiographs, and persistent pain after all conservative treatment measures have been exhausted. Osteoarthritis continues to be one of the key indications for knee arthroplasty, especially in people older than 50 years of age. In 2023, there were an estimated 571.5 million prevalent cases of osteoarthritis (knee or hip) in adults aged 45 years and older worldwide.

During the 2023–28 forecast period covered by this analysis, the global market for knee arthroplasty implants is projected to increase at a compound annual growth rate (CAGR) of 4.8%, from approximately $8,915.7m in 2023 to $11,287.7m in 2028.

If you are not a subscriber to Meddevicetracker and would like to purchase this report, please send an email to [email protected]. If you would like more information about obtaining a subscription to the Meddevicetracker database and report library, please send an email to [email protected].